The matrix metalloproteinase tissue inhibitor-4 (TIMP-4) may contribute to extracellular matrix deposition in SSc and its level is correlated with elevated SPAP in SSc patients (Gialafos et al., 2008). Here, TIMP4 is linked to systemic sclerosis.